Clinical trials
5 active studies led by Nyxoah S.A., of 8 in all
Source: ClinicalTrials.gov, Studies with Nyxoah S.A. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Nyxoah S.A. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Nyxoah S.A.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Stock listing
- NASDAQ: NYXH
- Type
- Medical devices
Source: SEC EDGAR, Company filings, CIK 1857190. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
1 510(k) clearances and PMA approvals since 2015
- Genio® System 2.1 Stimulator, Hypoglossal Nerve, Implanted, Apnea P240024 · 30 Jul 2026
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1857190.
Trials over time
Studies Nyxoah S.A. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Nyxoah S.A. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Nyxoah S.A.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Nyxoah S.A. is in.
From our blog
Stories on the topics Nyxoah S.A. works in.
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Stress and Mood Supplements: Ashwagandha and Beyond
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Sleep Aids: Why So Many People Can't Sleep
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Read